CGON CG Oncology, Inc.
CGON CG Oncology, Inc.
Healthcare · Biotechnology
Market read
POC $68.74 · VWAP $60.57 · -1.2% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
CGON Price Structure
Loading timeframes…
Peers
Every watchlist CGON belongs to, members best 30-day change first — CGON highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported the quarter ending 2026-06-30: revenue $1M, diluted EPS -$0.90, net income -$79M (SEC filing). Across the print the stock moved +2.3% (close before → first close after).
full note →Against street estimates
How CGON's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
CGON research tape
54 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.